Umoja appoints Seagen CEO as its board chairman
Seattle-based Umoja Biopharma on Monday named Clay Siegall as chairman of its board of directors.
Siegall is the CEO and co-founder of Bothell-based Seagen, a biotech company that went public on the Nasdaq in 2001. Siegall co-founded the company in 1998.
"Clay's vast scientific training and wealth of experience, particularly his emphasis on targeted cancer therapies and ability to build a com pany from drug discovery to commercial-stage, will be a crucial part of Umoja's continued growth," Andy…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Rick Morgan Source Type: news
More News: American Health | Biotechnology | Cancer | Cancer & Oncology | Cancer Therapy | Health Management | Training | Universities & Medical Training